Purpose 18 F-Fluorodeoxyglucose positron emission tomography (FDG PET) has been
used to assess metabolic response several months after stereotactic body radiotherapy …

PURPOSE: Routine assessment was made of tumor metabolic activity as measured by 18F-
fluorodeoxyglucose (FDG) positron emission tomography (PET) in Stage I non–small-cell …

Purpose Stereotactic body radiation therapy (SBRT) is considered the standard of care for
medically inoperable early-stage non-small cell lung cancer. There is mixed evidence on the …

Objective The prognostic value of metabolic parameters using 18F-fluorodeoxyglucose
positron emission tomography/computed tomography (FDG PET/CT) has not been …

Background: Early identification of patients who fail to lung stereotactic body radiation
therapy (SBRT) is vital as they can benefit from salvage therapy. Main guidelines …

Results The post-SBRT PET scan was obtained at∼ 3 months following treatment (range 2
to 6 months). At a median follow up of 16 months (range 3 months to 33 months), 3 local …

BACKGROUND AND PURPOSE: To test whether 18F-fluorodeoxyglucose (FDG) positron
emission tomography-computed tomography (PET-CT) imaging metrics correlate with …

BACKGROUND AND PURPOSE: The purpose was to characterize 18F-fluorodeoxyglucose-
positron emission tomography (FDG-PET) findings after stereotactic body radiation therapy …

The early response of lung tumours to stereotactic radiotherapy was prospectively evaluated
with 18F-fluorodeoxyglucose positron emission tomography-computed tomography. Three …

Purpose/Objective: Target volume delineation for stereotactic body radiation therapy (SBRT)
for pulmonary malignancies is typically based on CT imaging. Metabolic tumor information …